# A Study of BAX 888 in Male Adults With Severe Hemophilia A

> **NCT03370172** · PHASE1,PHASE2 · COMPLETED · sponsor: **Baxalta now part of Shire** · enrollment: 4 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **DRUG:** BAX 888

## Key facts

- **NCT ID:** NCT03370172
- **Lead sponsor:** Baxalta now part of Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-27
- **Primary completion:** 2024-07-09
- **Final completion:** 2024-07-09
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2025-09-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03370172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03370172, "A Study of BAX 888 in Male Adults With Severe Hemophilia A". Retrieved via AI Analytics 2026-09-16 from https://api.ai-analytics.org/clinical/NCT03370172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*